Effect of V0251 in acute vertigo. A randomized double blind placebo conrolled study
Effect of V0251 in acute vertigo. A randomized double blind placebo conrolled study
Effect of V0251 in Acute Vertigo
Effect of V0251 in acute vertigo. A randomized double blind placebo conrolled study
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
70
Years old
Gender
All
Therapeutic area :
Central Nervous System
Disease :
Symptomatic vertiginous crisis (acute vertigo)
Study medication :
Phase :
Phase II
Start Date :
June 16, 2012
End date :
April 15, 2013
Study ID :
V00251 IV 202 4A
EudraCT/CTIS number :
2011-003412-23
CT.gov Number :
NCT01583738
Send by email